Computer registration of uveitis patients.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 3428094)

Published in Doc Ophthalmol on March 10, 1988

Authors

A Kijlstra1, A Rothova, G S Baarsma, M J Zaal, M E Fortuin, C Schweitzer, E Glasius, P T de Jong

Author Affiliations

1: Netherlands Ophthalmic Research Institute, Amsterdam.

Articles by these authors

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05

Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67

The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08

Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06

Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75

Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci (1994) 3.37

The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30

Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19

Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet (2000) 2.89

Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82

Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80

The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol (1996) 2.47

Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43

Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31

Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol (1997) 2.28

Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis. J Clin Microbiol (1999) 2.21

Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol (1996) 2.20

Determinants of optic disc characteristics in a general population: The Rotterdam Study. Ophthalmology (1999) 2.09

Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci (2001) 2.04

Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol (1997) 2.04

Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol (1995) 2.02

Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol (1997) 2.01

von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia (1992) 2.01

Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol (1998) 1.98

Clinical features of acute anterior uveitis. Am J Ophthalmol (1987) 1.66

Interferon-alpha 2b for refractory ocular Behçet's disease. Lancet (1994) 1.65

Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology (1996) 1.65

Is basal laminar deposit unique for age-related macular degeneration? Arch Ophthalmol (1991) 1.61

Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol (1995) 1.59

Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study. Invest Ophthalmol Vis Sci (1997) 1.58

Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol (1994) 1.54

Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. Arch Ophthalmol (2001) 1.54

Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet (1993) 1.49

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med (1996) 1.48

Sorsby fundus dystrophy without a mutation in the TIMP-3 gene. Br J Ophthalmol (2000) 1.48

Dietary electrolyte intake and blood pressure in older subjects: the Rotterdam Study. J Hypertens (1996) 1.48

Retinitis pigmentosa: defined from a molecular point of view. Surv Ophthalmol (1999) 1.47

Presumed ocular histoplasmosis in The Netherlands--an area without histoplasmosis. Br J Ophthalmol (1997) 1.46

Epidemiology of age-related maculopathy. Epidemiol Rev (1995) 1.43

Herpes simplex virus type 1 (HSV-1)--induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann Neurol (2000) 1.42

Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology (2000) 1.39

Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology (1992) 1.37

Angiotensin levels in the eye. Invest Ophthalmol Vis Sci (1994) 1.36

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab (1989) 1.35

Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study. Diabetes (1995) 1.34

Visual loss in uveitis of childhood. Br J Ophthalmol (2003) 1.33

Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study. Am J Epidemiol (1999) 1.31

Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol (1997) 1.30

Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A (1999) 1.30

Intraocular light scattering in age-related cataracts. Invest Ophthalmol Vis Sci (1992) 1.29

Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol (1993) 1.29

Serology in ocular toxoplasmosis. Br J Ophthalmol (1986) 1.29

Risk factors for ocular sarcoidosis. Doc Ophthalmol (1989) 1.28

Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol (1989) 1.27

The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol (1987) 1.24

Pseudoxanthoma elasticum maps to an 820-kb region of the p13.1 region of chromosome 16. Genomics (1999) 1.24

Therapy for ocular toxoplasmosis. Am J Ophthalmol (1993) 1.24

Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond) (2012) 1.23

Detection of intraocular antibody production to herpesviruses in acute retinal necrosis syndrome. Am J Ophthalmol (1994) 1.21

Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 1.21

Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis (2006) 1.20

Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol (1993) 1.19

Morphologic changes in age-related maculopathy. Microsc Res Tech (1997) 1.19

Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study. Hypertension (1992) 1.14

Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol (2001) 1.14

Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol (2005) 1.12

Retinal detachment in ocular toxoplasmosis. Ophthalmology (2000) 1.11

Feedback regulation of the MBF transcription factor by cyclin Cig2. Nat Cell Biol (2001) 1.10

Fuchs' heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol (1994) 1.10

Isolated systolic hypertension and vessel wall thickness of the carotid artery. The Rotterdam Elderly Study. Arterioscler Thromb (1993) 1.10

The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci (1991) 1.09

Immunohistochemical light and electron microscopy of basal laminar deposit. Graefes Arch Clin Exp Ophthalmol (1994) 1.09

Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci (1994) 1.08

Intermediate uveitis: long-term course and visual outcome. Br J Ophthalmol (2008) 1.07

Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig. Curr Eye Res (1985) 1.07

Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol (1998) 1.07

Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res (1992) 1.06

Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol (1999) 1.06

Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol (1994) 1.06

Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol (1995) 1.03

HLA typing in birdshot chorioretinopathy. Am J Ophthalmol (1988) 1.03

Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res (1987) 1.03

Aqueous chamber taps in toxoplasmic chorioretinitis. Doc Ophthalmol (1986) 1.03